Evidencing the Future of Breast Radiotherapy: Insights from Dr. Rahimi
Por um escritor misterioso
Descrição
Accuray Dcember 12th, 2023 December 12th, 2023, 8am PsT | 11am EST | 5pm CET Presenter: Asal Rahimi, M.D., MS, Associate Professor, Chief of Breast Radiation, U.T. Southwestern Medical Center, Dallas, TX, USA Frank A. Vicini, M.D., FACR, FASTRO, FABS, Director of Research, Michigan Healthcare Professionals, Clinical Professor, Wayne State University School of Medicine, Board Certified […]
Roshni RAO, Chief, Division of Breast Surgery, Surgery
Recent Postoperative Radiotherapy for Left-sided Breast Cancer Does Not Increase Mortality of Heart Disease in Asians or Pacific Islanders: SEER Database Analysis
Frontiers Stereotactic partial breast irradiation in primary breast cancer: A comprehensive review of the current status and future directions
Economic burden of breast cancer: a case of Southern Iran, Cost Effectiveness and Resource Allocation
Full article: Effects of curcumin, its analogues, and metabolites on various cancers: focusing on potential mechanisms
International Stereotactic Radiosurgery Society (ISRS)
Potential Impact of Revised NCI Eligibility Criteria Guidance: Prior Malignancy Exclusion in Breast Cancer Clinical Trials in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 7 (2022)
Using population-based data to evaluate the impact of adherence to endocrine therapy on survival in breast cancer through the web-application BreCanSurvPred
Artificial intelligence in clinical decision support systems for oncology
BIOTECanada Insights Spring 2023 by BIOTECanada - Issuu
de
por adulto (o preço varia de acordo com o tamanho do grupo)
